To access this element change to forms mode OFF
Grant Award View - GA89326
The Long-term Outcomes of Lidocaine Infusions for persistent...
GA ID:
GA89326
Agency:
Department of Health and Aged Care
Approval Date:
25-May-2020
Publish Date:
29-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2025
Value (AUD):
$4,334,375.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF_RCRDUN_Neurological_Disorders_2020
Grant Activity:
The Long-term Outcomes of Lidocaine Infusions for persistent PostOperative Pain in patients undergoing breast surgery (LOLIPOP) Trial
Purpose:
Long lasting pain is common after breast cancer surgery. It is a common side effect of successful treatment, and is very difficult to treat. No intervention has been shown to prevent its occurrence. The LOLIPOP trial is a personalised medicine trial. It is a large study examining whether a local anaesthetic drug, lidocaine, given intravenously during and after surgery, will alter the risk of developing long-term pain in the wound of patients who undergo breast cancer surgery.
GO ID:
GO Title:
MRFF Clinical Trials Activity - RCRDUN Initiative – 2019 Neurological Disorders Grant Opportunity
Internal Reference ID:
MRF1200994
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, WA
Postcode:
Multiple
Country:
AUSTRALIA